Genome-Wide Analysis of Aberrant Position and Sequence of Plasma DNA Fragment Ends in Patients With Cancer

AFFECTION_STATUS - Case control status of the subject for cancer (phv00528152.v1.p1)

ANALYTE_TYPE - Analyte Type (phv00528154.v1.p1)
BODY_SITE - Site of sample collection (phv00528158.v1.p1)
COLLECTION_TUBE - Tube type for blood collection (phv00528161.v1.p1)
CONSENT - Consent group as determined by DAC (phv00528144.v1.p1)
EXTRACTION_KIT - Kit used for plasma cell-free DNA extraction (phv00528162.v1.p1)
IS_TUMOR - Tumor status (phv00528155.v1.p1)
SAMPLE_ID - Sample ID (phv00528153.v1.p1)
SAMPLE_ID - Sample ID (phv00528149.v1.p1)
SEQUENCER - Model of Illumina sequencer used for whole genome sequencing (phv00528163.v1.p1)
SOURCE_SUBJECT_ID - Subject ID used in the Source Repository (phv00528147.v1.p1)
SUBJECT_ID - Subject ID (phv00528143.v1.p1)
SUBJECT_ID - Subject ID (phv00528150.v1.p1)
SUBJECT_ID - Subject ID (phv00528148.v1.p1)
SUBJECT_SOURCE - Source repository where subjects originate (phv00528146.v1.p1)
TIMEPOINT - Order of this sample in longitudinal sample collection from the subject (phv00528159.v1.p1)
TIMEPOINT_DAY - Days from the first sample collection to this sample collection (phv00528160.v1.p1)
TUMOR_STAGE - Subject cancer stage at diagnosis (phv00528157.v1.p1)
TUMOR_TYPE - Subject cancer type if applicable (phv00528156.v1.p1)